Key points from article :
Cibinetide works via activating the body's innate repair receptor (IRR)
Capable of decreasing age-related decline in heart function.
Frailty score was also significantly lower in cibinetide-treated animals.
Greater healthspan observed near the end of life.
Cibinetide is currently in development by Araim Pharmaceuticals, Inc.